Clinical Trial Update: Optimization of Individualized Therapy for CRCs With Secondary RESISTance Towards Anti-EGFR Targeted Therapy Using an Avatar Model

View source ↗

Summary

A trial update describing efforts to optimize individualized therapy for colorectal cancer with secondary resistance to anti-EGFR treatment using an avatar-base…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Snippet

Sponsor: PD Dr. med. Volker Heinemann | Conditions: Colo-rectal Cancer, RAS Wild-type | Status: UNKNOWN